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FOCUS: 50 YEARS OF DNA REPAiR: THE YAlE SYMPOSiUM
REPORTS

cellular roles of dnA Polymerase Beta
Sreerupa Ray, Miriam Rose Menezes, Alireza Senejani, and Joann
B. Sweasy*
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut

Since its discovery and purification in 1971, DNA polymerase ß (Pol ß†) is one of the most
well-studied DNA polymerases. Pol ß is a key enzyme in the base excision repair (BER)
pathway that functions in gap filling DNA synthesis subsequent to the excision of damaged
DNA bases. A major focus of our studies is on the cellular roles of Pol ß. We have shown
that germline and tumor-associated variants of Pol ß catalyze aberrant BER that leads to genomic instability and cellular transformation. Our studies suggest that Pol ß is critical for the
maintenance of genomic stability and that it is a tumor suppressor. We have also shown
that Pol ß functions during Prophase i of meiosis. Pol ß localizes to the synaptonemal complex and is critical for removal of the Spo11 complex from the 5’ ends of double-strand
breaks. Studies with Pol ß mutant mice are currently being undertaken to more clearly understand the function of Pol ß during meiosis. in this review, we will highlight our contributions from our studies of Pol ß germline and cancer-associated variants.

introduction
DNA polymerase beta (Pol ß) was
originally purified from rabbit bone marrow by Chang and Bollum and characterized as a low molecular weight DNA
polymerase [1]. Several years later, Abbotts
and Wilson subcloned the cDNA of both
human and rat Pol ß and successfully expressed this protein in Escherichia coli [2],

permitting large quantities of active enzyme to be purified and studied.
Pol ß is a 39 kDa protein with DNA
polymerase and deoxyribose phosphatase
(dRP lyase) activities [2-4]. It belongs to
the X family of DNA polymerases. DNA
polymerase β is expressed in all stages of
the cell cycle and in all of the analyzed tissues [5,6]. Since the time of its cloning and
purification, Pol ß has become one of the
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most highly studied DNA polymerases. In
this overview, we will discuss our contributions to elucidating the mechanism of DNA
synthesis of Pol ß with particular regard to
variants of this enzyme identified in the
germlines of humans in tumors.
Joann Sweasy (JS) performed her graduate work with Evelyn Witkin on the roles of
E. coli recA mutants in SOS mutagenesis
and the restart of DNA synthesis cultivated
an interest in the study of DNA polymerases
[7-9]. This led her to join Lawrence Loeb’s
laboratory, where she began research on Pol
ß. To understand the mechanisms of substrate choice by Pol ß, JS set out to characterize mutator variants of Pol ß.
Identification of mutator variants in human
or mouse cells would be difficult, so, drawing upon her previous experience as a graduate student, she decided to develop a
complementation system in E. coli, and,
using the Pol ß cDNA clone generously
given to the laboratory by Dr. Samuel Wilson, showed that rat Pol ß could substitute
for E. coli Pol I in the joining of Okazaki
fragments during DNA replication [10]. This
permitted JS to use E. coli mutation reporters to identify Pol ß mutator mutants
[11]. JS carried a box full of Pol ß mutator
variants [12] with her to her new faculty position in the Department of Therapeutic Radiology at Yale School of Medicine, a
department with an incredible history of research in DNA repair that she was very enthusiastic to join. Since that time, JS’s
laboratory has characterized many of these
mutator variants of Pol ß, showing how
amino acid residues of Pol ß distant from the
active site are critical for accurate DNA synthesis. In addition to this work, JS became
interested in understanding the cellular roles
of Pol ß and initiated work in this area using
polymorphic and cancer-associated variants
of Pol ß, and this is the focus of this
overview.
Pol ß And BAse excision rePAir
Pol ß functions in base excision repair
(BER), a major genome maintenance pathway in mammalian cells that is responsible

for removal and repair of at least 20,000
DNA lesions per cell per day [13]. The simplest and most common form of BER is
short patch BER, which can be initiated by
one of several different DNA glycosylases,
each having preferences for specific types of
lesions [14]. Monofunctional DNA glycosylases recognize DNA lesions and catalyze
the hydrolysis of the N-glycosylic bond to
generate an abasic site. The abasic site is
nicked at its 5’ side by the APE1 endonuclease, leaving a 3’OH and a 5’deoxyribose
phosphate (dRP). Pol ß fills in the single nucleotide gap and catalyzes removal of the
dRP group. Bifunctional glycosylases,
which usually recognize oxidative lesions,
generate an abasic site and then catalyze its
removal via ß-elimination to generate a
3’dRP and 5’phosphate. APE1 then removes
the 3’dRP, leaving a 3’OH, to which Pol ß
can bind and fill in the resulting single nucleotide gap. In both cases, the XRCC1/Ligase IIIα or XRCC1/Ligase I complex
catalyzes ligation of the resulting ends. An
alternative BER pathway that does not depend on APE1 is utilized when the NEIL
glycosylases initiate repair [15]. NEIL 1, 2,
and perhaps 3 catalyze excision of the damaged base via ß,δ elimination, leaving a
3’phosphate and a 5’phosphate. The 3’phosphate is removed by polynucleotide kinase,
leaving a gap that is most often filled by Pol
ß, followed by ligation. Therefore, Pol ß is
required for all forms of BER.
Germline VAriAnts of Pol ß
Five hundred sixty-seven SNPs have
been identified in the 33 Mb POLB gene, of
which only 22 are found within the coding
region [16,17]. Two missense germline variants of Pol β have been identified in the
human population. These are R137Q
(rs12678588) and P242R (rs3136797),
which have been reported to be present in 0.6
percent and 2.4 percent, respectively, of the
human population [18]. The P242R variant
was specifically identified in Keralites and
Europeans. The R137Q Pol ß variant has reduced polymerase activity and an impaired
interaction with PCNA. When expressed in
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figure 1. mechanisms of genomic instability generated by Pol ß variant proteins.
The DNA substrate for Pol ß is usually a single nucleotide gap with a 5’dRP group (red)
that is generated upon excision of a damaged base. A mutator variant of Pol ß will remove
the dRp group using its dRp lyase activity and fill in the gap in an error-prone manner, inducing mutations (denoted by X). A Pol ß variant with slow polymerase activity (low activity
variant) will remove the dRp group, but not fill in all gaps in the cell, leading to the accumulation of BER intermediates and eventually to genomic instability. Failure to remove the
dRp group by a Pol ß variant with slow dRp lyase activity will also result in the accumulation of BER intermediates and genomic instability.

Pol β-deficient MEFs, R137Q confers sensitivity to the DNA damaging agents methyl
methanesulfonate (MMS) and N-methyl-Nnitrosourea (MNU) [19]. Pol β P242R also
catalyzes DNA synthesis with a reduced rate
[20]. In human mammary epithelial cells,
P242R Pol β induces chromosomal aberrations and cellular transformation, suggesting
a putative role for P242R Pol β as a cancer
driver [20]. The mechanistic basis underlying the generation of chromosomal aberrations is the slow BER gap filling catalyzed
by P242R. Unfilled gaps in the proximity of
the replication fork lead to the induction of
double-strand breaks and can result in chromosomal aberrations, as shown in Figure 1.
The studies on Pol β R137Q and P242R suggest that individuals with these variants have
an increased risk of developing cancer. This
hypothesis is currently being tested using
mouse models.
tumor-AssociAted Pol ß VAriAnts
Small-scale sequencing studies have revealed that POL B is mutated in 30 percent
to 40 percent of human tumors, including
colon, gastric, and prostate carcinomas

[21,22]. Interestingly, the resulting amino
acid alterations are not localized to one particular domain of Pol β but are widespread
across the protein [22].
Colon Tumor-Associated Pol ß Variants
The K289M Pol ß variant was identified
in a colon carcinoma [23]. We showed that
K289M is a sequence context-dependent
mutator in mouse cells and that it induced
mutations at a 16-fold greater frequency
within a sequence nearly identical to a highly
mutated sequence in the APC gene, the mutation of which results in colon cancer [24].
Work from our laboratory also demonstrated
that expression of K289M in immortal but
non-transformed mouse cells induces cellular transformation through a mutational
process as shown in Figure 1 [25].
Given this result, our laboratory sequenced the exons 5’ and 3’ UTRs of the
POL B gene from colon tumors and found
that 40 percent of these tumors carried a mutation in the coding region of POL B that
was not found in normal tissue [22]. A subset of these variants that were predicted by
mathematical algorithms to be damaging exhibited reduced DNA polymerase activity.
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We showed that two of these variants,
G231D and E295K, which was also identified in a gastric carcinoma [26], induce
chromosomal aberrations and cellular transformation [27,28]. The G231D variant has a
low affinity for the incoming nucleotide due
to a disordered active site once bound to
DNA [27]. E295K appears to lack DNA
polymerase activity as a result of its inability to assume an active polymerase conformation [28,29]. During BER, neither of
these variants fills single nucleotide gaps in
an efficient manner, leading to the accumulation of BER intermediates and resulting in
an increase in double-strand breaks and genomic instability (Figure 1). The E288K
variant was also identified in a colon carcinoma [22]. Interestingly, this variant is a sequence context-dependent mutator and
prefers to misincorporate nucleotides opposite template A, which could result in a mutator phenotype in human cells [30].
Gastric Carcinoma-Associated Pol ß
Variants
In addition to E295K, Pol β L22P,
Y265C, and D160N were identified in
human gastric carcinomas [26]. L22P has
low affinity for DNA and very low dRP
lyase activity [31]. The expression of L22P
in Pol β deficient mouse embryo fibroblasts
(MEFs) results in sensitivity to MMS and
cellular transformation in immortalized
mouse cells, likely as a result of the accumulation of BER intermediates [31]. Y265C
catalyzes DNA synthesis at a significantly
slower rate than WT Pol ß and is also a mutator polymerase [11,32,33]. In mouse LN12
cells, expression of Y265C leads to an 8-fold
increase in mutation frequency, and the
types of mutations induced include point
mutations and small deletions [32]. Y265C
has normal dRP lyase activity [34]. We recently constructed the Y265C Pol β knockin mouse model [34]. The homozygous
mutant animals are born at the expected
Mendelian ratio; however, they are small
and 60 percent die within a few hours post
birth. The POL B Y265c/c E11 and E14 embryos and newborn mice are 33 percent
smaller (p < 0.0001) than their wild-type and

heterozygous littermates [34]. We showed
that MEFs isolated from these mice exhibit
slow proliferation. Significantly higher levels of apoptosis were observed in the POL B
Y265c/c
MEFs versus MEFs from wild-type
mice. In combination, these results indicate
that both slow proliferation and increased
cell death contribute to the small size of the
c/c mice [34]. We showed that BER intermediate substrates accumulate in the POL B
Y265c/c
MEFs in the form of unfilled gaps and
that these substrates resulted in increased
levels of chromosomal aberrations. The
D160N variant, also identified in a gastric
carcinoma, induces complex tandem mutations that appear to be template-dependent
[35]. We suggest that the active site of this
variant exists in a conformation that can accommodate movement of the DNA substrate, permitting complex mutations to be
generated.
Prostate Cancer-Associated Pol ß Variant
The I260M prostate cancer-associated
variant is a sequence context-dependent base
substitution mutator [36] that also induces insertions of dinucleotide repeats within runs
of the same types of repeats. Expression of
I260M in immortal but non-transformed
mouse epithelial cells results in cellular
transformation by a mutational mechanism
[25] (Figure 1, mutator phenotype).
In summary, Pol ß variants have the potential to drive cancer by induction of a mutator phenotype or genomic instability, as
shown in Figure 1. Our results suggest that
during the gap filling step of BER, which
occurs at least 20,000 times per cell per day,
some of the Pol ß variants, including I260M,
insert the incorrect nucleotide, eventually resulting in a mutation. Should the mutation
occur within key growth control genes, it
could lead to cancer. For example, we
showed that expression of I260M in mouse
epithelial cells led to mutation of PPARγ, resulting in global alterations in gene expression [37]. Interestingly, PPARγ has been
suggested to function as a tumor suppressor.
In contrast, many of the Pol ß variants fill
single nucleotide gaps less efficiently than
WT Pol ß, leading to accumulation of BER
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intermediates that result in chromosomal
aberrations and cellular transformation.
BER is a highly coordinated process, and
our results suggest that imbalances in this repair pathway have the potential to lead to
cancer. In combination, our results suggest
that Pol β is critical for the repair of endogenous DNA damage and the maintenance of genomic stability.
role of dnA PolymerAse β in
meiosis
Meiosis involves a highly orchestrated
process of cell division wherein diploid cells
undergo two successive divisions to produce
four haploid germ cells. Meiotic recombination involves physical interaction between
homologous chromosomes, which form chiasmata and lead to crossover products [38].
The meiotic recombination pathway is induced by formation of DNA double strand
breaks (DSBs) by the meiosis-specific
Spo11 complex, a relative of archeal topoisomerase VI [39], during the leptotene substage of Prophase I [40]. DSBs are marked
by formation of γH2AX foci, a phosphorylated version of H2A. DSBs are repaired
through the pachytene substage of Prophase
I in processes resulting in crossover and
non-crossover products [39]. Synapsis occurs between chromosomes and genetic exchange is facilitated by synaptonemal
complex (SC) formation. Upon introduction
of DSBs, Rad51, a RecA homolog in eukaryotes promotes homology search and
DNA strand invasion. Dmc1, a meiosis-specific protein, also promotes homology-directed DNA strand exchange that leads to
crossover products. The homologs synapse
in the zygotene substage of Prophase I [41].
During the diplotene substage, the homologs
desynapse and crossovers are formed which
are an essential outcome of meiotic recombination [41]. The crossovers are observed
as chiasmata [42,43]. The enzymes involved
in the catalysis of DNA synthesis during
meiosis are not well characterized.
DNA polymerases are known to function
in DNA replication, repair, and recombination. Interestingly, expression of DNA Pol β
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is highest in mouse testis, suggesting that it
may have a role in meiosis [44]. Recently it
has also been shown that overexpression of
Pol β stimulates Rad51-dependent homologous recombination in mammalian cells [45].
We initiated our studies of Pol ß in
meiosis in collaboration with Terry Ashley
and attempted to localize Pol ß to the SC.
We showed that Pol ß foci were present on
the SC during Prophase I of meiosis in a pattern consistent with the idea that this enzyme
functions in DSB repair during this process
[44]. Deletion of the POL B gene in mice
leads to lethality, thus to characterize the
role of Pol β in meiosis, we employed the
Cre-loxP gene targeting system to delete the
POL B gene specifically in primordial germ
cells. Synapsis is defective in spermatocytes
and oocytes isolated from these mice. Importantly, Pol β-deficient spermatocytes
have persistent Spo11-induced γH2AX
DSBs and a significantly reduced level of
Spo11-complex removal from the 5’ end of
the DSB. Thus Pol β has a very critical role
in meiosis that is associated with the removal of the Spo 11 complex [41]. We suggest that Pol ß can act as a “landing
platform” for other proteins that are required
for Spo 11 removal. Alternatively, Pol ß
could facilitate formation of a DNA structure, which is conducive to removal of
Spo11. Additional experiments are being
conducted to more clearly define the role of
the Pol ß protein in Prophase I of meiosis.
conclusions And outlook
Experiments from our laboratory have
shown that Pol ß functions in DNA repair
and during Prophase I of meiosis. Pol ß
functions to maintain genomic stability during DNA BER. Both germline and cancerassociated variants lead to aberrant DNA
repair that is either error-prone or inefficient,
resulting in the accumulation of BER intermediates. Therefore, Pol ß somatic and
germline variants have the potential to be
cancer drivers and to impact cancer therapy.
We have also shown that Pol ß functions
during Prophase I of meiosis, although its
precise role during this process is not
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known. This has led us to characterize meiosis in mice that express various Pol ß variants and these experiments are currently
under way.
Acknowledgment: This work was supported
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to JBS.
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